Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Prostate Cancer News
PROSTATE CANCER ADVISOR
Prostate Cancer News
Salvage Cryotherapy for Recurrent PCa May Provide Long-Term Oncologic Control
Salvage cryotherapy is emerging as a viable local treatment option for prostate cancer that recurs following radiation treatment.
Prostate Cancer ADT Not Linked to Greater Cardiovascular Mortality
Androgen deprivation therapy added to radiation therapy (RT) for unfavorable-risk prostate cancer is not associated with an increased risk for cardiovascular mortality compared with RT alone, even among patients with preexisting cardiovascular disease, a study found.
Black and White Men Had Similar Outcomes After Radical Prostatectomy
Black men were less likely to receive androgen deprivation therapy and had lower use of secondary treatment with radiotherapy.
Nonmetastatic CRPC Treatments Compared for Efficacy and Safety
Investigators compared the efficacy, safety, and costs of abiraterone, darolutamide, enzalutamide, and apalutamide in treating nmCRPC.
Genomic Prostate Score for Risk Assessment of Long-Term Outcomes in Localized Prostate Cancer
A team of researchers sought to evaluate the association between the Genomic Prostate Score and long-term outcomes in patients having undergone radical prostatectomy for prostate cancer.
British Study Reveals No Race Disparity in Survival in mCRPC Cases
Overall, Black and White men with metastatic castration-resistant prostate cancer had similar median overall survival times, according to a British study.
Ultra-High Single-Dose Radiation Therapy Tested for Prostate Cancer
In a small phase 2 trial involving men with intermediate-risk prostate cancer, a single ultra-high dose of radiation was safe and comparable to curative hypofractionated stereotactic body radiation therapy in tumor control and quality-of-life measures.
Open, Robotic-Assisted Prostate Surgery Have Similar Cumulative Costs
Robotic-assisted radical prostatectomy is associated with higher costs than open radical prostatectomy at the index hospitalization for the surgery, but it is associated with less healthcare use during the 1 year after discharge.
Cryoablation Plus ADT for Newly Diagnosed Metastatic PCa Improves Outcomes
In a propensity score-based study, prostate cryoablation added to androgen deprivation therapy (ADT) improved failure-free survival and survival without castration-resistant disease compared with ADT alone.
5-ARIs Shown to Benefit Men on Prostate Cancer AS
Men who take 5-alpha-reductase inhibitors while on active surveillance for prostate cancer are less likely to experience cancer progression, according to a new study
Bipolar Androgen Therapy Effective in Metastatic Castration-Resistant Prostate Cancer
The goal of the TRANSFORMER study was to compare the effects of bipolar androgen therapy with enzalutamide in asymptomatic men with castration-resistant prostate cancer who have experienced disease progression while receiving treatment with abiraterone.
Prevalence of Uncontrolled, Untreated Cardiovascular Risk Factors in Patients With Prostate Cancer
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.
Salvage Prostatectomy Complication Rates Differ by Primary PCa Therapy
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
MRI-Based Algorithm More Predictive of Biochemical Recurrence After Prostate Cancer Surgery Than Existing Prognostic Tools
A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate cancer.
Findings May Guide Use of Salvage Partial Gland Ablation for Recurrent PCa
A new study of men with recurrent prostate cancer following radiation therapy shows that biopsy findings and MRI can reliably identify index lesions for possible salvage partial gland ablation.
Cardiovascular Risk Factors Undertreated in Veterans With Prostate Cancer
In a study, 1 in 4 male veterans with prostate cancer failed to receive a comprehensive assessment of their cardiovascular risk factors.
Prostate Cancer Bone Metastasis Burden Tied to Prostate RT Survival Benefit
The overall and failure-free survival benefit of adding prostate radiation therapy to standard of care for metastatic prostate cancer declines with increasing number of bone metastases, a study found.
FUS Ablation Feasible for Intermediate-Risk Prostate Cancer
In small phase II study, 93 percent free of clinically significant prostate cancer at treatment site at five-month biopsy.
MRI May Have a Role in Community-Based Prostate Cancer Screening
Biparametric magnetic resonance imaging may offer advantages over PSA testing and ultrasonography by detecting more clinically significant prostate cancers without increasing the number of men advised to undergo prostate biopsies or overdiagnosed with clinically insignificant cancers.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
